Lauren Sciences

Lauren Sciences is a biotechnology company specializing in the development of targeted drug delivery systems for central nervous system (CNS) disorders and oncology. The company's core technology is the V-Smart™ platform, which utilizes proprietary nanovesicles designed to encapsulate and deliver therapeutic agents across the blood-brain barrier (BBB). This platform enables the systemic, non-invasive administration of drugs, including small molecules, peptides, and biologics, that are typically excluded from the brain. Lauren Sciences is currently advancing a pipeline of candidates for high-need indications such as Parkinson's disease, amyotrophic lateral sclerosis (ALS), and glioblastoma. By overcoming the challenges of the BBB, the company aims to transform the treatment landscape for neurodegenerative diseases and brain cancers.